Aprea Therapeutics, Inc., a biopharmaceutical firm that specializes in precision oncology through synthetic lethality, declared that the first patient has been dosed in the ACESOT-1051 phase 1 study. The study evaluates which is evaluating the...
MGI, an organization focused on building center instruments and advances that drive development in life science, declared partnership with SeqOne, a leading provider of artificial intelligence driven genomic choice support software...
AstraZeneca's Imfinzi (durvalumab) has been approved as a treatment for adult patients with mismatch repair deficient (dMMR) primary, advanced, or recurrent endometrial cancer, in the United States. This can be followed by Imfinzi...
Alembic Pharmaceuticals Ltd announced that the US health agency has granted final approval for its generic Icatibant injectable, which is recommended for the treatment of acute bouts of hereditary angioedema in adults. Alembic Pharmaceuticals...
LED Radiofluidics Corporation, a preclinical biotechnology firm committed to the development of efficient PET radiotracers, and Premium Imaging Inc, a biotechnology company with extensive experience in the clinical transformation and marketing of...
Takeda has signed an option agreement with Ascentage Pharma to enter into an exclusive license agreement for olverembatinib, an oral, potentially best-in-class, third-generation BCR-ABL tyrosine kinase inhibitor (TKI) that is currently being...
The US Food and Drug Administration (FDA) has approved AstraZeneca's Farxiga (dapagliflozin) for improving glycaemic control in children with type-2 diabetes (T2D) aged 10 and older. The positive outcomes of the paediatric T2NOW phase III trial...
Suven Pharmaceuticals, which is backed by PE company Advent International, said that it has reached a definitive agreement to acquire a controlling stake in Hyderabad-based contract research development organization (CDMO) Sapala Organic for...
Cumulus Neuroscience, a worldwide digital health company dedicated to improving data for neuroscience clinical trials and patient care, has announced a collaboration with the Digital Health Measurement Collaborative Community (DATAcc) of the...
NewAmsterdam Pharma Organization N.V., a clinical biopharmaceutical organization creating oral, non-statin prescriptions for patients at risk of cardiovascular disease (CVD) with raised low-density lipoprotein cholesterol (LDL-C), for whom...
, CDSCO.jpg)
.jpg)